Related Experiment Video
Updated: Aug 29, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Growth hormone insensitivity syndrome associated with syringomyelia and type I Chiari malformation
Junko Takagi1, Kazuo Otake, Masahiko Takahashi
1Department of Laboratory Medicine, Aichi Medical University School of Medicine, 21 Karimata, Nagakute, Aichi 480-1195.
Abstract:
A 49-year-old man with syringomyelia and a Type I Arnold-Chiari malformation (Chiari-I) was diagnosed with growth hormone insensitivity syndrome (GHIS). He was short in stature, had high circulating levels of GH, and low circulating levels of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3). His GH responses to the administration of growth hormone-releasing hormone (GHRH) and L-DOPA were normal, but his levels of IGF-I and IGFBP-3 did not increase after the administration of exogenous GH. Direct genomic DNA sequencing revealed neither a mutation nor deletion in this patient's GH receptor (GHR) gene, though one polymorphism was detected, indicating that his GHR gene was normal. This is the first reported case of an association of GHIS with syringomyelia and Chiari-I malformation.
Related Concept Videos
Huntington Disease l: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Type II Diabetes II: Pathophysiology
Hypoglycemia and Glucagon
Type I Diabetes I: Introduction
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: